Core Viewpoint - Anbiping has received the Medical Device Registration Certificate for its HPV nucleic acid detection kit, which enhances its product offerings in the cervical cancer detection market [1] Group 1: Product Development - The HPV nucleic acid detection kit utilizes real-time fluorescence PCR method for qualitative detection of 18 high-risk HPV DNA types in cervical samples [1] - The product also includes subtype detection for HPV16 and HPV18, which are significant in cervical cancer diagnosis [1] Group 2: Market Expansion - The new product complements the existing HPV detection products of the company, thereby broadening its market presence in cervical cancer screening [1] - The acquisition of the registration certificate supports the company's strategic layout in the tumor screening and diagnosis sector [1]